Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-08642534 and Itraconazole Drug-Drug Interaction Study in Healthy Adults
NCT07575945Phase 1Completed
- Sponsor
- Pfizer
- Start
- May 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PF-08642534, sponsored by Pfizer. Primary endpoint: Area Under the Curve From Time Zero to Last Quantifiable Concentration. Started May 2026; status: completed.
02
Drugs
PF-08642534
Beyond the preview
Go deeper on NCT07575945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07575945.